Svetlana Lopata, DPM
Primary Podiatric Medicine · Bronx, NYNPI 1902393655
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,180 of the $1,757 with a category attached, or 67.2%. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 32.8% of the total.
Across 29 payments — averaging $60.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$577
- Kerecis Limited$304
- Integra Lifesciences Corporation$300
- Inari Medical, Inc.$195
- Advanced Oxygen Therapy Inc.$149
- KCI USA, Inc.$47
- plus $186 from 7 others
What the payments were for
- Food & beverage$1,18067%
- Education$57733%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 3 | $577 |
| Kerecis Limited | 2 | $304 |
| Integra Lifesciences Corporation | 10 | $300 |
| Inari Medical, Inc. | 1 | $195 |
| Advanced Oxygen Therapy Inc. | 3 | $149 |
| KCI USA, Inc. | 2 | $47 |
| Stryker | 2 | $45 |
| Organogenesis Inc. | 1 | $39 |
| Nevro Corp. | 1 | $25 |
| AbbVie | 1 | $23 |
| Bioventus LLC | 1 | $19 |
| Convatec Inc. | 1 | $18 |
| Biocomposites Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,757 in reported general payments places this provider in the 75th percentile of 85 primary podiatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 36 | $22,893 |
| Doxepin Hcl | 62 | $7,798 |
| Clotrimazole | 177 | $4,272 |
| Ammonium Lactate | 88 | $2,073 |
| Ciclopirox | 14 | $720 |
| Ketoconazole | 12 | $200 |
| Mupirocin | 18 | $185 |
| Nystatin | 13 | $180 |
| Diclofenac Sodium | 17 | $162 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $80 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Bronx
- Martin WendelkenBronx$14K
- Michael MerensteinBronx$4K
- Joann BilelloBronx$1K
- Jerome LeffBronx$676
- Raphael RamanBronx$481
- Anna StoupineBronx$416
- Jason LacherBronx$383
- Enid GorisBronx$263
- Anthony IorioNorth Salem$177K
- Brian StraussYonkers$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.